Latest News - Atopic Dermatitis

Tuesday, August 15, 2017 | PracticalDermatology.com, PracticalDermatology.com, PuraCap

PuraCap Pharmaceuticals Introduces EpiCeram Quad Pack

PuraCap® Pharmaceutical is introducing the EpiCeram® Controlled Release Skin Barrier Emulsion Quad Pack, which contains four 100-gram airless pumps. EpiCeram® is a US Food and Drug Admi…

Read the full story

Tuesday, August 01, 2017 | PracticalDermatology.com

Glenmark Pharmaceuticals Reports Positive Phase 2a Data for GBR 830 for Atopic Dermatitis

Glenmark Pharmaceuticals shared positive data from a Phase 2a study of GBR 830, an investigational, anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis (AD). The study evaluated the …

Read the full story

Thursday, July 27, 2017 | Personnel/Company News, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Product Launches and Updates, Atopic Derm, Atopic Dermatitis , Eczema, Psoriasis, Valeant NJ

Valeant’s Newly Minted Ortho Dermatologic Unit Makes Big Splash at Summer AAD

It’s go big or go home for the newly re-branded Valeant Ortho Dermatologic division. At the 2017 American Academy of Dermatology in New York City, the company will officially launch …

Read the full story

Monday, July 10, 2017 | Personnel/Company News, PracticalDermatology.com, PracticalDermatology.com, Celgene

Dr. Jacqualyn Fouse Named Executive Chairman of Dermavant

Dr. Jacqualyn "Jackie" Fouse is the new Executive Chairman of Dermavant Sciences. Part of the Roivant Sciences family of companies, Dermavant Sciences is developing and, upon regulatory a…

Read the full story

Wednesday, June 28, 2017 | PracticalDermatology.com, National Eczema Association

HydroLotion Scores National Eczema Association Seal of Acceptance

Theraplex Company’s HydroLotion Daily Skin Moisturizer now has the National Eczema Association (NEA) Seal of Acceptance. The light-weight moisturizer for the face and body is hypoallergenic, …

Read the full story

Monday, June 19, 2017 | PracticalDermatology.com, Research and Publications, Eczema

CARD11 Mutations May Lead to AD

Researchers have identified mutations in a gene called CARD11 that may lead to atopic dermatitis. Their findings, reported in Nature Genetics, also suggest that some of these defects…

Read the full story

Monday, June 19, 2017 | PracticalDermatology.com, Research and Publications

Study Findings Cast Doubt on Link Between Eczema and Cardiovascular Disease

Despite recent findings to the contrary, a new study in the British Journal of Dermatology has found that eczema is likely not associated with an increase in cardiovascular risk factors or diseases. …

Read the full story

Tuesday, June 06, 2017 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Product Launches and Updates

FDA Clears Clarify Medical Core Technology for At-home UVB Phototherapy

The US Food and Drug Administration has cleared the Clarify Medical Phototherapy System for marketing, and the new smart, at-home UVB phototherapy system will be available to patients with chronic ski…

Read the full story

Tuesday, May 23, 2017 | PracticalDermatology.com, PracticalDermatology.com, Research and Publications, Psoriasis

Tweaking TWEAK May Cool Inflammation in Pso and AD

New research pinpoints a common driver of skin inflammation in both psoriasis and atopic dermatitis. The findings, published in the May 22, 2017 issue of Nature Communications, showed that TWE…

Read the full story

Thursday, May 04, 2017 | Personnel/Company News, PracticalDermatology.com, PracticalDermatology.com, Atopic Dermatitis , Eczema, Leo

LEO Pharma U.S. Welcomes Judit H. Nyirady as Vice President of Medical Strategy & Scientific Affairs

Judit H. Nyirady, MD, MBA, is the new Vice President of Medical Strategy & Scientific Affairs at LEO Pharma Inc. In this role, she will be responsible for the medical and scientific affairs str…

Read the full story

Wednesday, April 19, 2017 | PracticalDermatology.com, PracticalDermatology.com, Research and Publications, Atopic Derm, Atopic Dermatitis , Eczema

Topical Cannabinoids May Soothe Itchy Skin

Cannabinoids contain anti-inflammatory properties that may make them useful in the treatment of a wide-range of skin diseases including  eczema, psoriasis, atopic and contact dermatitis, accordin…

Read the full story

Tuesday, March 28, 2017 | FDA Approval/Clearance, PracticalDermatology.com, Regeneron, Sanofi

FDA Approves New Eczema Drug Dupixent

The FDA has approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema (atopic dermatitis). Regeneron Pharmaceuticals, Inc.'s Dupixent is intended for patients whose ec…

Read the full story

Monday, March 20, 2017 | PracticalDermatology.com, PracticalDermatology.com, Research and Publications

No Antibiotics Needed For Mild Infected Eczema in Kids

Oral or topical antibiotics are not effective for treating milder clinically infected eczema in children, a new study shows. In the study of 113 children with clinical, non-severely infected eczema…

Read the full story

Tuesday, March 07, 2017 | PracticalDermatology.com, Research and Publications

New Research Closes In On Personalized AD Therapy

New research on skin lipids may pave the way toward personalized therapies for atopic dermatitis. Researchers can now identify the precise lipids found in the skin of people who have atopic dermati…

Read the full story

Wednesday, March 01, 2017 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Research and Publications

Skin Diseases Remain Major Cause of Disability

Skin diseases are the fourth leading cause of disability worldwide, according to the Global Burden of Disease 2013 Study which appears online in JAMA Dermatology. For the study, researchers estimat…

Read the full story
Load More